Free Trial

Canopy Growth (TSE:WEED) Shares Up 2.8% - Time to Buy?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) shares were up 2.8% during mid-day trading on Thursday . The company traded as high as C$2.62 and last traded at C$2.55. Approximately 497,471 shares traded hands during trading, a decline of 69% from the average daily volume of 1,625,473 shares. The stock had previously closed at C$2.48.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on WEED shares. ATB Capital cut their price target on shares of Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating on the stock in a report on Monday, February 10th. Canaccord Genuity Group dropped their target price on shares of Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating on the stock in a research note on Monday, February 10th. Four investment analysts have rated the stock with a sell rating and one has given a hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Reduce" and an average price target of C$5.64.

Get Our Latest Research Report on Canopy Growth

Canopy Growth Trading Up 8.1%

The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39. The company has a market capitalization of C$431.13 million, a P/E ratio of -0.39, a PEG ratio of -0.01 and a beta of 1.79. The company's fifty day simple moving average is C$1.68 and its 200-day simple moving average is C$3.07.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines